T. Rowe Price reports 5.7% stake in Atmus
T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 4,677,937 shares of Atmus Filtration Technologies common stock, representing 5.7% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 4,677,937 shares of Atmus Filtration Technologies common stock, representing 5.7% of the class as of 12/31/2025. The firm reports sole voting power over 4,561,818 shares and sole dispositive power over 4,677,884 shares, with no shared voting or dispositive power. It certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Atmus.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Atmus Filtration Technologies (ATMU) stock does T. Rowe Price Associates own?
Does this Schedule 13G say T. Rowe Price aims to influence control of Atmus (ATMU)?
Who is the reporting person in this Atmus Filtration (ATMU) Schedule 13G filing?
What is the relevant event date for T. Rowe Price’s Atmus (ATMU) ownership report?
What type of securities in Atmus Filtration (ATMU) are covered in this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.